Pharm
Sulfonylurea Overdose
search
Sulfonylurea Overdose
, Sulfonylurea Toxicity, Sulfonylurea Poisoning
See Also
Unknown Ingestion
Causes
Oral
Sulfonylurea
antihyperglycemic medications (
Chlorpropamide
,
Glipizide
,
Glyburide
)
Findings
Signs and Symptoms
Confusion
Coma
Decreased Appetite
Dizziness
Hypoglycemia
Lethargy
Seizure
s
Weakness (
Hemiparesis
may occur)
Precautions
One Pill Can Kill
Even a single tablet can cause symptomatic
Hypoglycemia
in children
Risk of delayed or prolonged
Hypoglycemia
Agent half-lives vary, but range from 2-36 hours (in
Overdose
, may last >24 hours)
Hepatic excretion is typical for
Sulfonylurea
s
Evaluation
See
Unknown Ingestion
Management
Adults
Dextrose 50%
(0.5 g/ml, or 25 g per 50 ml vial)
Administer 25 gram ampule (up to 1-2 ml/kg or 1 g/kg) IV bolus
Followed by continuous infusion (dose based on degree of
Hypoglycemia
)
Avoid dextrose monotherapy (triggers
Insulin
release, and prolonged
Hypoglycemia
)
Octreotide
(
Sandostatin
)
Dose: 50-150 mcg/dose SQ twice to three times daily (or 50 mcg every 6 hours)
Blocks pancreatic beta-islet cell
Insulin
release
Glucagon
Dose: 1 mg IM/SQ per dose and may repeat every 20 minutes
Only transient elevation in
Glucose
to temporize until definitive other management (esp.
IV Access
)
Management
Children
Dextrose bolus followed by continuous infusion
See
Dextrose Rule of 50
Age 1 to 24 months:
Dextrose 25%
(0.25 g/ml) IV 2-4 ml/kg
Age >24 months:
Dextrose 50%
(0.5 g/ml) IV 1-2 ml/kg
Avoid dextrose monotherapy (triggers
Insulin
release, and prolonged
Hypoglycemia
)
Octreotide
(
Sandostatin
)
Dose: 1 to 1.5 mcg/kg (up to 50 mcg) SQ every 6 hours
Blocks pancreatic beta-islet cell
Insulin
release
Glucagon
Infants: 0.025 mg/kg/dose every 20 minutes
Children: 0.5 mg/dose every 20 minutes
Only transient elevation in
Glucose
to temporize until definitive other management (esp.
IV Access
)
Management
Disposition
Adults - Asymptomatic
Observe for 8-12 hours for delayed
Hypoglycemia
Adults -
Hypoglycemia
See
Hypoglycemia Management
Observe for 24 hours
Children
Observe for 24 hours
References
Riddle and Tomaszewski (2018) Crit Dec Emerg Med 32(2): 32
Harrigan (2001) Ann Emerg Med 38(1): 68-78 [PubMed]
Rath (2008) J Paeditr Child Health 44(6): 383-4 [PubMed]
Vega (2024) Am Fam Physician 109(2): 143-53 [PubMed]
Type your search phrase here